• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Impact of incretin-related agents on endothelial cell function

    2017-04-09 08:18:33HiroshiNomotoHideakiMiyoshiAkinobuNakamuraTatsuyaAtsumiNaokiMandaYoshioKuriharaShinAokionbehalfofSAISStudyGroup

    Hiroshi Nomoto, Hideaki Miyoshi, *, Akinobu Nakamura, Tatsuya Atsumi, Naoki Manda, Yoshio Kurihara,Shin Aoki, on behalf of SAIS Study Group^

    1 Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    2 Manda Memorial Hospital, Sapporo, Japan

    3 Kurihara Clinic, Sapporo, Japan

    4 Aoki Clinic, Sapporo, Japan

    INTRODUCTION

    Prevention of atherosclerotic diseases, such as cardiovascular disease (CVD) and stroke is an issue that should be resolved in patients with type 2 diabetes mellitus because they have a higher risk of these conditions.1 Recent comprehensive care of patients with risk factors dramatically decreased diabetic macro- and microvascular complications,2but the mortality rate is still higher in populations with diabetes.3Therefore, detection and management of the earlier phases of atherosclerosis is important. It has been reported that endothelial cell damage precedes progressive atherosclerosis and these dysfunctions are known to be individual risk factors for CVD in type 2 diabetes mellitus.4,5For the relationship between therapeutics and endothelial cell function, numerous studies have been performed, and statins6and angiotensin II receptor blockers7 along with some anti-diabetic agents were reported to improve endothelial dysfunction.8,9

    In recent years, incretin-related drugs such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1(GLP-1) analogues, have been available to treat patients with type 2 diabetes mellitus and their anti-atherosclerotic potentials had been expected based on many in vitro studies and animal models. However, some longitudinal studies failed to verify their superiority for the prevention of CVD.10-12Moreover, their effects on endothelial cell function have been inconsistent.13We performed two different randomized controlled trials that focused on endothelial cell function, using different incretin-related agents, the DPP-4 inhibitor sitagliptin and the GLP-1 receptor agonist liraglutide. Results of these clinical trials demonstrated that both medications did not improve endothelial cell function assessed by flow-mediated dilatation. Here, we will introduce them and discuss the effects of incretin-related therapy on the early phase of atherosclerosis.

    THE EFFECT OF INCRETIN-RELATED THERAPY ON ENDOTHELIAL CELL FUNCTION

    We investigated whether incretin-related drugs improve endothelial cell function using flow-mediated dilatation(FMD) of the brachial artery. FMD is known to be a less-invasive tool that reflects endothelial nitric oxide bioavailability to evaluate endothelial cell function, and a reversible marker of early phase of atherosclerosis.14Additionally, a recent meta-analysis showed that improvement of FMD was significantly related to the relative risk reduction in cardiovascular events.15Thus, treatments that have favorable effects on FMD might be ideal for prevention form cardiovascular outcomes. We conducted two open-label, multicenter, prospective randomized parallel-group comparison studies comparing sitagliptin versus glimepiride (SAIS-1)16and liraglutide versus insulin glargine (SAIS-2)17(Table 1). Briefly, patients with type 2 diabetes mellitus who did not have severe atherosclerotic diseases were randomly assigned to each treatment, and underwent treatment for 26 or 14 weeks, respectively.FMD and biochemical assessment were performed before and after the treatment periods, and all FMD measurements were conducted under controlled conditions by a well-trained technician who was blinded to the study to minimize the introduction of potential confounding variables. For FMD, neither sitagliptin nor liraglutide affected endothelial cell function in this treatment periods,and neither did glimepiride and glargine (Table 2). Some previous clinical trials suggested that GLP-1 analogues and DPP-4 inhibitors improved FMD,18-20but there is some controversy including the lack of a control group,the study duration, the subject populations, and FMD measurement accuracy. Assessment of FMD is so sensitive that the results were greatly affected by many internal and environmental factors, such as patients’ background (sex,age, obesity, heart rate and smoking),21conditions (air temperature, mental/physical stress),22-24and the medications described above. There were opposing results and opinions about the relationship between incretin agents and FMD results.25,26Our studies fully controlled these confounding factors and both treatment groups were similarly controlled for glycemic metabolism. Moreover,another assessment method for endothelial dysfunction,End-PAT, also showed the same results. A recent metaanalysis revealed that efficacy of GLP-1-based therapies on FMD was confirmed only in cross-sectional studies but not in longitudinal studies.13It was reported that native GLP-1 infusion for several hours to individuals with type 2 diabetes resulted in improvement in endothelial function.27,28Although both GLP-1 and cleaved GLP-1,such as GLP-1(9–36) and GLP-1(28-36), may cause these effects, a study comparing the effect of native GLP-1 on vascular function with or without of sitagliptin to prevent an increase of the cleaved form of GLP-1 resulted in no detectable changes in both groups.29Although the existence of the GLP-1 receptor on the vascular endothelium has been suggested, recent accumulating evidence showed that the endothelium does not possess the GLP-1 receptor,30,31but there is currently no consensus. Thus, beneficial effects of incretin-related therapy on atherosclerotic changes may be mainly explained by indirect mechanisms rather than by direct action on endothelial cells.

    EFFECTS ON BETA-CELL FUNCTION AND ATHEROSCLEROSIS

    Incretin-related agents exert glucose-lowering effects in a blood glucose-dependent manner,32and they also play an important role in avoiding hypoglycemia by diminishing insulin secretion and preventing glucagon secretion under normal-to-hypoglycemic conditions.33Numerous in vitro and animal model experiments verified protective and proliferative effects of incretin-related agents on pancreatic beta-cells, and our prospective studies also demonstrated that both a DPP-4 inhibitor and a GLP-1 analogue showed incremental beta-cell functions, assessed by surrogate markers of insulin secretion (Table 2). Similarly, some clinical trials using incretin agents clarified incremental beta-cell function.34,35Effects of a GLP-1 analogue on beta-cell signaling include activating adenylate cyclase/protein kinase A, phosphatidylinositol 3-kinase/Akt, and the adenosine monophosphate kinase/mTOR cascades, which results in proliferation of beta-cells in rodents. However, the precise signaling of GLP-1 analogues has not been fully determined in humans.36Additionally, pancreatic beta-cells are known to be sensitive to oxidative stresses that result from relatively low expression levels of anti-oxidant enzymes, suchas superoxide dismutase, catalase, and glutathione peroxidase.37GLP-1 exerts anti-oxidant effects via suppression of nitric acid synthase expression in pancreatic beta-cells.38DPP-4 inhibitors were reported to reduce apoptosis in pancreatic beta-cells39,40and induce anti-oxidant responses,41and such mechanisms might be beneficial for protection of beta-cells from some kinds of stresses.

    Table 1: Inclusion criteria and outline of the original studies

    Table 2: Summary of the original studies

    In addition, long-term administration of these agents showed favorable effects on anti-oxidant, anti-atherosclerotic, and lipid metabolism in our study. One of the DPP-4 inhibitors, sitagliptin, ameliorated HDL-cholesterol via increasing adiponectin, anti-oxidant responses, and serum TNF-α levels. However, the GLP-1 analogue, liraglutide,caused a reduction of oxidative stress and improvement in cardiac load and atherosclerosis (Table 2). Incretinrelated drugs including DPP-4 inhibitors have been shown to have favorable effects on atherosclerosis via mediating several pathways, attenuating TNF-α-mediated induction of plasminogen activator inhibitor-1 expression,42preventing reactive oxygen species-induced cell senescence in endothelial cell lines,43increasing serum adiponectin levels,44suppressing macrophage-related inflammation, and inhibiting DPP-4-induced smooth muscle proliferation.45.

    Despite these many favorable mechanisms, many clinical trials using DPP-4 inhibitors failed to show their superiority to placebo in CVD outcomes.10-12One of the possible reasons is that these trials mainly included patients with atherosclerotic diseases. Therefore, even such potent agents may not be enough to suppress advanced atherosclerotic diseases. Earlier intervention may be beneficial for patients with early-phase atherosclerosis.

    CONCLUSIONS

    Accumulating evidence suggests that incretin-based therapy has anti-atherosclerotic effects and favorable effects on pancreatic beta-cells. However, the long-term results on endothelial cell function have not yet been determined. Our clinical trials provided direct evidence that these agents did not improve endothelial cell function in patients with type 2 diabetes, although their favorable effects on beta-cells and atherosclerosis are expected and will be assessed in the future.

    Conflicts of interest

    Author contributions

    HN and HM designed the original study. HN contributed to the writing the manuscript. HM and TA revised the manuscript. All authors contributed to enrollment of patients and approved the final manuscript.

    Plagiarism check

    This paper was screened twice using CrossCheck to verify originality before publication.

    Peer review

    This paper was double-blinded and stringently reviewed by international expert reviewers.

    1. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet.2010;375:2215-2222.

    2. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med.2014;370:1514-1523.

    3. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56:2601-2608.

    4. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA.2002;287:2570-2581.

    5. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev. 2001;22:36-52.

    6. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T.Low-density lipoprotein-independent improvement of flowmediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. Int J Cardiol.2012;158:285-289.

    7. Li S, Wu Y, Yu G, Xia Q, Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One. 2014;9:e90217.

    8. Papathanassiou K, Naka KK, Kazakos N, et al. Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis.2009;205:221-226.

    9. Wascher TC, Schmoelzer I, Wiegratz A, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. Eur J Clin Invest. 2005;35:551-557.

    10. Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med.2015;373:232-242.

    11. White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369:1327-1335.

    12. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.N Engl J Med. 2013;369:1317-1326.

    13. Song X, Jia H, Jiang Y, et al. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 diabetes Mellitus: a meta-analysis. Sci Rep.2015;5:10202.

    14. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation.2007;115:1285-1295.

    15. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631-640.

    16. Nomoto H, Miyoshi H, Furumoto T, et al. A randomized controlled trial comparing the effects of sitagliptin and glimepiride on endothelial function and metabolic parameters: Sapporo athero-incretin study 1 (SAIS1). PLoS One.2016;11:e0164255.

    17. Nomoto H, Miyoshi H, Furumoto T, et al. A comparison of the effects of the GLP-1 analogue liraglutide and insulin glargine on endothelial function and metabolic parameters: a randomized, controlled trial Sapporo athero-incretin study 2 (SAIS2).PLoS One. 2015;10:e0135854.

    18. Kubota Y, Miyamoto M, Takagi G, et al. The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes. J Korean Med Sci. 2012;27:1364-1370.

    19. Noda Y, Miyoshi T, Oe H, et al. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: a preliminary report. Cardiovasc Diabetol.2013;12:8.

    20. Irace C, De Luca S, Shehaj E, et al. Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research. Diab Vasc Dis Res. 2013;10:72-77.

    21. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community:the Framingham Heart Study. Circulation. 2004;109:613-619.

    22. Iwata M, Miyashita Y, Kumagai H. Seasonal variation of endothelium-dependent flow-mediated vasodilation measured in the same subjects. Am J Cardiovasc Dis. 2012;2:111-115.

    23. Amir O, Alroy S, Schliamser JE, et al. Brachial artery endothelial function in residents and fellows working night shifts. Am J Cardiol. 2004;93:947-949.

    24. Spieker LE, Hurlimann D, Ruschitzka F, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002;105:2817-2820.

    25. Ayaori M, Iwakami N, Uto-Kondo H, et al. Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J Am Heart Assoc. 2013;2:e003277.

    26. Hopkins ND, Cuthbertson DJ, Kemp GJ, et al. Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients. Diabetes Obes Metab. 2013;15:770-773.

    27. Ceriello A, Novials A, Canivell S, et al. Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory,antiinflammatory, and antioxidant action in type 2 diabetes.Diabetes Care. 2014;37:1938-1943.

    28. Nystrom T, Gutniak MK, Zhang Q, et al. Effects of glucagonlike peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab. 2004;287:E1209-1215.

    29. Devin JK, Pretorius M, Nian H, Yu C, Billings FTt, Brown NJ.Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm. J Am Heart Assoc. 2014;3.

    30. Pyke C, Knudsen LB. The glucagon-like peptide-1 receptor--or not? Endocrinology. 2013;154:4-8.

    31. Richards P, Parker HE, Adriaenssens AE, et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes. 2014;63:1224-1233.

    32. Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes.2013;62:3316-3323.

    33. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulindependent) diabetic patients. Diabetologia. 1993;36:741-744.

    34. Retnakaran R, Kramer CK, Choi H, Swaminathan B, Zinman B.Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care.2014;37:3270-3278.

    35. Leibowitz G, Cahn A, Bhatt DL, et al. Impact of treatment with saxagliptin on glycaemic stability and beta-cell function in the SAVOR-TIMI 53 study. Diabetes Obes Metab. 2015;17:487-494.

    36. Tuduri E, Lopez M, Dieguez C, Nadal A, Nogueiras R. Glucagon-like peptide 1 analogs and their effects on pancreatic islets.Trends Endocrinol Metab. 2016;27:304-318.

    37. Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.Biochem J. 1981;199:393-398.

    38. Jimenez-Feltstrom J, Lundquist I, Salehi A. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell Tissue Res. 2005;319:221-230.

    39. Mu J, Woods J, Zhou YP, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic betacell mass and function in a rodent model of type 2 diabetes.Diabetes. 2006;55:1695-1704.

    40. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes. 2008;57:1331-1339.

    41. Shah P, Ardestani A, Dharmadhikari G, et al. The DPP-4 inhibitor linagliptin restores beta-cell function and survival in human isolated islets through GLP-1 stabilization. J Clin Endocrinol Metab. 2013;98:E1163-1172.

    42. Liu H, Hu Y, Simpson RW, Dear AE. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression. J Endocrinol. 2008;196:57-65.

    43. Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells. Horm Metab Res. 2011;43:731-734.

    44. Hibuse T, Maeda N, Kishida K, et al. A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus--a randomized controlled trial START-J study. Cardiovasc Diabetol. 2014;13:96.

    45. Ervinna N, Mita T, Yasunari E, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154:1260-1270.

    精品酒店卫生间| 99热国产这里只有精品6| 国产精品人妻久久久影院| 国产精品一区二区在线不卡| a 毛片基地| 高清毛片免费看| 伦精品一区二区三区| 久久热精品热| 爱豆传媒免费全集在线观看| 午夜91福利影院| 飞空精品影院首页| 国产在线免费精品| 亚洲欧美精品自产自拍| 搡女人真爽免费视频火全软件| 黄片播放在线免费| 日本黄色片子视频| 精品人妻熟女毛片av久久网站| 制服丝袜香蕉在线| 一边亲一边摸免费视频| 熟女人妻精品中文字幕| 日韩精品免费视频一区二区三区 | 免费观看在线日韩| 少妇人妻久久综合中文| 成人漫画全彩无遮挡| 国产在视频线精品| 亚洲精品国产av蜜桃| 国产毛片在线视频| av免费观看日本| 青春草亚洲视频在线观看| 五月天丁香电影| 中文字幕人妻熟人妻熟丝袜美| 大香蕉久久网| 九九久久精品国产亚洲av麻豆| 免费观看性生交大片5| 韩国高清视频一区二区三区| 人人妻人人爽人人添夜夜欢视频| 欧美人与性动交α欧美精品济南到 | 国产精品久久久久久久久免| 国产精品一区二区三区四区免费观看| 精品国产乱码久久久久久小说| 人人妻人人添人人爽欧美一区卜| 欧美日韩亚洲高清精品| 国产精品.久久久| av免费观看日本| 黄色怎么调成土黄色| 建设人人有责人人尽责人人享有的| 日韩欧美一区视频在线观看| 天天操日日干夜夜撸| 一本—道久久a久久精品蜜桃钙片| 美女内射精品一级片tv| 中文字幕免费在线视频6| 免费看不卡的av| 久久热精品热| 精品久久久久久久久av| 午夜激情av网站| 青春草视频在线免费观看| 美女脱内裤让男人舔精品视频| 69精品国产乱码久久久| 男男h啪啪无遮挡| 999精品在线视频| 欧美人与善性xxx| 国产精品成人在线| 久久人人爽av亚洲精品天堂| 丝袜在线中文字幕| 国产精品一区二区三区四区免费观看| 色婷婷av一区二区三区视频| 性色avwww在线观看| 黑人巨大精品欧美一区二区蜜桃 | 日本色播在线视频| 嫩草影院入口| 亚洲少妇的诱惑av| 我的老师免费观看完整版| 777米奇影视久久| 在现免费观看毛片| 赤兔流量卡办理| 一级,二级,三级黄色视频| 2018国产大陆天天弄谢| 下体分泌物呈黄色| 欧美激情 高清一区二区三区| 免费高清在线观看视频在线观看| 在线观看国产h片| 亚洲欧美日韩另类电影网站| 国产精品国产av在线观看| 久久久亚洲精品成人影院| 大片电影免费在线观看免费| 免费黄色在线免费观看| 亚洲久久久国产精品| 街头女战士在线观看网站| 成人18禁高潮啪啪吃奶动态图 | 欧美最新免费一区二区三区| 久久人人爽人人爽人人片va| 午夜激情福利司机影院| 国产在线视频一区二区| av免费在线看不卡| 国产成人aa在线观看| 秋霞伦理黄片| 午夜av观看不卡| 视频中文字幕在线观看| 久久精品国产a三级三级三级| 色网站视频免费| 一本色道久久久久久精品综合| 国产精品久久久久成人av| 国产亚洲av片在线观看秒播厂| 成人免费观看视频高清| 国产一区亚洲一区在线观看| 亚洲欧美中文字幕日韩二区| 久久亚洲国产成人精品v| 91午夜精品亚洲一区二区三区| av一本久久久久| 99热这里只有是精品在线观看| 亚洲国产精品999| 欧美日韩在线观看h| 久久精品久久精品一区二区三区| 中文字幕人妻熟人妻熟丝袜美| 永久网站在线| 亚洲情色 制服丝袜| 国产精品久久久久久精品古装| 人妻制服诱惑在线中文字幕| 美女国产视频在线观看| 熟女人妻精品中文字幕| 国产精品.久久久| 亚洲av男天堂| 狂野欧美白嫩少妇大欣赏| 午夜福利,免费看| 婷婷色综合大香蕉| 国内精品宾馆在线| 日韩一区二区视频免费看| av网站免费在线观看视频| 男女高潮啪啪啪动态图| 国产爽快片一区二区三区| 久久国产精品大桥未久av| 爱豆传媒免费全集在线观看| 日本黄色片子视频| 一级毛片黄色毛片免费观看视频| a级毛片免费高清观看在线播放| 丰满饥渴人妻一区二区三| 尾随美女入室| 女人精品久久久久毛片| 99热6这里只有精品| 伦精品一区二区三区| 又大又黄又爽视频免费| 简卡轻食公司| www.av在线官网国产| 国产国拍精品亚洲av在线观看| 国产精品久久久久久精品电影小说| 午夜视频国产福利| 成人国产麻豆网| 日韩免费高清中文字幕av| 日韩电影二区| 3wmmmm亚洲av在线观看| av女优亚洲男人天堂| 在线播放无遮挡| 精品久久久久久久久亚洲| 嫩草影院入口| 亚洲不卡免费看| 免费观看在线日韩| xxxhd国产人妻xxx| 少妇熟女欧美另类| a级片在线免费高清观看视频| 欧美日韩精品成人综合77777| 国语对白做爰xxxⅹ性视频网站| 免费人成在线观看视频色| 免费人妻精品一区二区三区视频| 免费观看无遮挡的男女| 日韩电影二区| 免费播放大片免费观看视频在线观看| 免费观看的影片在线观看| 国产午夜精品一二区理论片| 精品一区二区免费观看| 麻豆乱淫一区二区| 国产高清不卡午夜福利| 丰满迷人的少妇在线观看| 熟妇人妻不卡中文字幕| 亚洲精品亚洲一区二区| 一本大道久久a久久精品| 午夜免费男女啪啪视频观看| 久久久久久久久大av| 黄色视频在线播放观看不卡| 免费av不卡在线播放| 高清av免费在线| 丝袜在线中文字幕| 国产精品 国内视频| 久久久久久久精品精品| 久久婷婷青草| 亚洲伊人久久精品综合| 欧美亚洲日本最大视频资源| 高清黄色对白视频在线免费看| 99九九线精品视频在线观看视频| 国产日韩欧美在线精品| 成人手机av| 久久午夜福利片| 考比视频在线观看| 黑人高潮一二区| 性色av一级| 精品国产露脸久久av麻豆| 成人影院久久| 一级爰片在线观看| 国产精品秋霞免费鲁丝片| 曰老女人黄片| 大陆偷拍与自拍| 欧美另类一区| 亚洲第一av免费看| 26uuu在线亚洲综合色| 女性被躁到高潮视频| 欧美+日韩+精品| 大码成人一级视频| 黑人巨大精品欧美一区二区蜜桃 | 久久久国产一区二区| 妹子高潮喷水视频| 国产成人精品久久久久久| 国产综合精华液| av在线老鸭窝| 免费播放大片免费观看视频在线观看| 韩国高清视频一区二区三区| 天堂中文最新版在线下载| 视频中文字幕在线观看| 午夜视频国产福利| 久久久久久久久大av| 久久精品国产亚洲网站| 人成视频在线观看免费观看| 精品国产国语对白av| 国产精品人妻久久久久久| 亚洲综合色惰| 欧美成人精品欧美一级黄| 久久99一区二区三区| 成人影院久久| 国产欧美日韩一区二区三区在线 | 欧美日韩视频高清一区二区三区二| 亚洲国产精品成人久久小说| 久久国产精品男人的天堂亚洲 | 蜜臀久久99精品久久宅男| 2018国产大陆天天弄谢| 青春草国产在线视频| 欧美变态另类bdsm刘玥| 国产精品无大码| 9色porny在线观看| 欧美成人精品欧美一级黄| 日日摸夜夜添夜夜添av毛片| 美女主播在线视频| videossex国产| 精品亚洲乱码少妇综合久久| 插逼视频在线观看| 啦啦啦在线观看免费高清www| 美女cb高潮喷水在线观看| 中文字幕人妻熟人妻熟丝袜美| 看十八女毛片水多多多| 国产精品秋霞免费鲁丝片| 亚洲精品av麻豆狂野| 国产精品一二三区在线看| 国产午夜精品一二区理论片| 成人黄色视频免费在线看| 久久人人爽av亚洲精品天堂| 九九爱精品视频在线观看| 不卡视频在线观看欧美| 美女主播在线视频| av卡一久久| 欧美 日韩 精品 国产| 久久久久国产网址| 少妇的逼好多水| 亚洲图色成人| 免费观看a级毛片全部| 亚洲四区av| 国产精品一区二区三区四区免费观看| 中文字幕最新亚洲高清| 秋霞伦理黄片| 午夜激情久久久久久久| 天堂俺去俺来也www色官网| 欧美激情 高清一区二区三区| 交换朋友夫妻互换小说| 99re6热这里在线精品视频| 午夜av观看不卡| 亚洲成人手机| 久久这里有精品视频免费| 午夜av观看不卡| 国产精品女同一区二区软件| 国产精品蜜桃在线观看| 国产成人精品在线电影| 亚洲综合色惰| 久久精品久久久久久久性| 最近中文字幕2019免费版| av天堂久久9| 久久精品国产a三级三级三级| 男女啪啪激烈高潮av片| xxxhd国产人妻xxx| 亚洲国产精品国产精品| 高清黄色对白视频在线免费看| 黑人欧美特级aaaaaa片| 丁香六月天网| 只有这里有精品99| 一级毛片我不卡| av在线老鸭窝| 亚洲一区二区三区欧美精品| 久久这里有精品视频免费| 久久久久久久久久久免费av| 少妇被粗大猛烈的视频| 一级毛片我不卡| 国产精品国产av在线观看| 一区在线观看完整版| 亚洲精品国产av成人精品| 日韩欧美一区视频在线观看| av福利片在线| 一本大道久久a久久精品| 久久婷婷青草| 欧美亚洲 丝袜 人妻 在线| 免费大片18禁| 亚洲人成网站在线观看播放| 精品久久久久久久久av| 成年女人在线观看亚洲视频| 精品久久蜜臀av无| 欧美精品高潮呻吟av久久| 又大又黄又爽视频免费| 亚洲人成网站在线播| av在线观看视频网站免费| 五月天丁香电影| 国产有黄有色有爽视频| 一区二区三区免费毛片| 老司机影院毛片| 国产成人免费无遮挡视频| 在线精品无人区一区二区三| 久久综合国产亚洲精品| 日韩成人伦理影院| 中国国产av一级| 久久久精品免费免费高清| 亚洲精品色激情综合| 乱人伦中国视频| 久久精品国产自在天天线| 国产精品一二三区在线看| 日韩av不卡免费在线播放| 亚洲四区av| 熟女电影av网| 免费观看的影片在线观看| 久久久久久久久久人人人人人人| 热re99久久国产66热| 黄色配什么色好看| 91久久精品国产一区二区成人| 麻豆成人av视频| 国产视频首页在线观看| 国产又色又爽无遮挡免| 国产片内射在线| 一级毛片aaaaaa免费看小| 亚洲精品色激情综合| 国产亚洲精品第一综合不卡 | 啦啦啦在线观看免费高清www| 国产亚洲精品第一综合不卡 | 最后的刺客免费高清国语| 国产精品.久久久| 啦啦啦中文免费视频观看日本| 考比视频在线观看| 精品一区二区免费观看| a级毛色黄片| 免费高清在线观看日韩| 成人影院久久| 又黄又爽又刺激的免费视频.| 最新的欧美精品一区二区| 久久国产亚洲av麻豆专区| 午夜影院在线不卡| 欧美bdsm另类| 狂野欧美激情性bbbbbb| 夫妻性生交免费视频一级片| 青春草亚洲视频在线观看| 精品亚洲乱码少妇综合久久| 久久99蜜桃精品久久| 亚洲综合精品二区| 精品人妻熟女毛片av久久网站| 亚洲一级一片aⅴ在线观看| 亚洲精品第二区| 国产精品一区二区在线观看99| 国产男女内射视频| 久久精品国产亚洲av天美| 人体艺术视频欧美日本| 观看美女的网站| tube8黄色片| 成人手机av| 亚洲av免费高清在线观看| 国产在线视频一区二区| 91久久精品国产一区二区三区| 午夜视频国产福利| 美女xxoo啪啪120秒动态图| 亚洲欧美成人精品一区二区| 午夜免费鲁丝| 看十八女毛片水多多多| 国语对白做爰xxxⅹ性视频网站| 美女脱内裤让男人舔精品视频| 国语对白做爰xxxⅹ性视频网站| 高清午夜精品一区二区三区| 免费日韩欧美在线观看| 中文天堂在线官网| 午夜激情福利司机影院| 国产精品一国产av| 高清毛片免费看| www.色视频.com| 91成人精品电影| 亚洲精品色激情综合| 免费少妇av软件| 高清av免费在线| 精品人妻在线不人妻| 91久久精品国产一区二区三区| 在线观看一区二区三区激情| 日韩av免费高清视频| 人妻 亚洲 视频| 久久ye,这里只有精品| 在线播放无遮挡| 观看美女的网站| www.av在线官网国产| 亚洲成人手机| 亚洲欧美一区二区三区黑人 | 王馨瑶露胸无遮挡在线观看| 国产熟女欧美一区二区| 简卡轻食公司| 国产精品成人在线| 久久久久久人妻| 99热网站在线观看| 精品视频人人做人人爽| 搡老乐熟女国产| 人人妻人人爽人人添夜夜欢视频| 久久韩国三级中文字幕| 高清午夜精品一区二区三区| 午夜激情av网站| 2022亚洲国产成人精品| 美女视频免费永久观看网站| 精品久久久久久电影网| 欧美97在线视频| 男女边吃奶边做爰视频| 亚洲久久久国产精品| 中文字幕av电影在线播放| 免费高清在线观看日韩| 成年人午夜在线观看视频| 中文天堂在线官网| 热re99久久精品国产66热6| 精品国产乱码久久久久久小说| 久久久久久久久久久丰满| 亚州av有码| 一级毛片aaaaaa免费看小| 搡老乐熟女国产| 免费看光身美女| 男男h啪啪无遮挡| 日本免费在线观看一区| 狂野欧美白嫩少妇大欣赏| 亚洲美女黄色视频免费看| 中文字幕免费在线视频6| 女人精品久久久久毛片| 两个人免费观看高清视频| av天堂久久9| 国产欧美亚洲国产| 美女cb高潮喷水在线观看| 欧美精品人与动牲交sv欧美| 国产精品一二三区在线看| av福利片在线| 亚洲av成人精品一区久久| 精品久久久久久久久av| 国产成人一区二区在线| 男男h啪啪无遮挡| 精品熟女少妇av免费看| 一边摸一边做爽爽视频免费| 日韩中字成人| tube8黄色片| 欧美另类一区| www.av在线官网国产| 国产在视频线精品| 日韩av不卡免费在线播放| av女优亚洲男人天堂| 国产黄色免费在线视频| 国产欧美日韩一区二区三区在线 | 91精品国产国语对白视频| 久久狼人影院| 男女高潮啪啪啪动态图| 国产在线免费精品| 色婷婷久久久亚洲欧美| 街头女战士在线观看网站| 老熟女久久久| 一级a做视频免费观看| 久久亚洲国产成人精品v| 国产高清有码在线观看视频| 全区人妻精品视频| 久久人人爽人人片av| 久久精品久久久久久噜噜老黄| 国产高清三级在线| 又粗又硬又长又爽又黄的视频| 18+在线观看网站| 高清不卡的av网站| 日本-黄色视频高清免费观看| 最近的中文字幕免费完整| 亚洲精品日韩av片在线观看| av在线老鸭窝| 成人18禁高潮啪啪吃奶动态图 | 中国国产av一级| 国产白丝娇喘喷水9色精品| 欧美 亚洲 国产 日韩一| 日韩av在线免费看完整版不卡| 妹子高潮喷水视频| 日韩大片免费观看网站| 亚洲精品一二三| 免费观看无遮挡的男女| 我的老师免费观看完整版| 久久久精品区二区三区| 久久久久久伊人网av| 久久这里有精品视频免费| 国产高清有码在线观看视频| 亚洲国产精品一区二区三区在线| 妹子高潮喷水视频| 一本—道久久a久久精品蜜桃钙片| 国产又色又爽无遮挡免| 精品少妇内射三级| 免费观看在线日韩| 亚洲四区av| 中文字幕人妻丝袜制服| 人人妻人人添人人爽欧美一区卜| 国产精品嫩草影院av在线观看| 免费高清在线观看日韩| 久久午夜福利片| 成人亚洲欧美一区二区av| 少妇猛男粗大的猛烈进出视频| 人妻制服诱惑在线中文字幕| 黄色怎么调成土黄色| 国产精品.久久久| 一本久久精品| 人妻夜夜爽99麻豆av| 下体分泌物呈黄色| 亚洲精品自拍成人| 超碰97精品在线观看| 婷婷色综合大香蕉| 十八禁高潮呻吟视频| 在线观看免费日韩欧美大片 | 精品酒店卫生间| 国产av国产精品国产| 免费大片黄手机在线观看| 18禁在线播放成人免费| 欧美激情 高清一区二区三区| 99九九线精品视频在线观看视频| 亚洲欧美成人精品一区二区| 成人漫画全彩无遮挡| 人人妻人人爽人人添夜夜欢视频| 观看美女的网站| 日韩,欧美,国产一区二区三区| 久久国产亚洲av麻豆专区| videosex国产| 精品久久久精品久久久| 免费观看av网站的网址| 色婷婷久久久亚洲欧美| 男女啪啪激烈高潮av片| 少妇熟女欧美另类| 黄片无遮挡物在线观看| 久久精品久久久久久久性| 观看av在线不卡| 蜜桃久久精品国产亚洲av| 视频区图区小说| 国产日韩欧美亚洲二区| 一级毛片 在线播放| 又黄又爽又刺激的免费视频.| 国产男女内射视频| 国产成人精品福利久久| 下体分泌物呈黄色| 免费播放大片免费观看视频在线观看| 99久久精品一区二区三区| 日本av手机在线免费观看| 寂寞人妻少妇视频99o| 嘟嘟电影网在线观看| 少妇的逼好多水| 性高湖久久久久久久久免费观看| 免费黄色在线免费观看| 日日撸夜夜添| 99国产精品免费福利视频| 日韩亚洲欧美综合| 国产熟女午夜一区二区三区 | 亚洲国产精品一区三区| 国产av码专区亚洲av| 婷婷色av中文字幕| 精品午夜福利在线看| 黄色配什么色好看| 欧美xxxx性猛交bbbb| 日本vs欧美在线观看视频| 国产毛片在线视频| 日韩亚洲欧美综合| 久久精品久久久久久噜噜老黄| 赤兔流量卡办理| 日韩欧美精品免费久久| 欧美精品一区二区免费开放| 亚洲三级黄色毛片| 久久韩国三级中文字幕| 蜜臀久久99精品久久宅男| 欧美精品高潮呻吟av久久| 最近中文字幕高清免费大全6| 中文天堂在线官网| 国产乱人偷精品视频| 男女国产视频网站| 免费观看av网站的网址| 亚洲精品国产av蜜桃| 精品一区在线观看国产| 夜夜看夜夜爽夜夜摸| 美女视频免费永久观看网站| 有码 亚洲区| 欧美日韩综合久久久久久| a级毛色黄片| 又粗又硬又长又爽又黄的视频| 国产白丝娇喘喷水9色精品| 久久人人爽人人片av| av又黄又爽大尺度在线免费看| 岛国毛片在线播放| 亚洲精品第二区| 日韩中文字幕视频在线看片| 国产成人精品福利久久| 亚洲欧美日韩另类电影网站| 久久久久视频综合| 在线精品无人区一区二区三| 欧美日韩av久久| 女人精品久久久久毛片| 久久久久国产网址| 亚洲欧美日韩另类电影网站| 精品久久蜜臀av无| 色94色欧美一区二区| 丰满饥渴人妻一区二区三| 国产男女内射视频| 国产有黄有色有爽视频| 18禁动态无遮挡网站| 精品一区在线观看国产|